Grantclosed🌐 United StatesPAR-23-267

Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)

National Institutes of Health

Details?

Posted: Apr 18, 2023
Response deadline: Dec 9, 2025, 12:00 AM UTC
Type: Grant
Category: 93.350
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-23-267

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
United States · Apr 18, 2023
Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
United States · Jun 17, 2025
Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)
United States · Jun 17, 2025
Collaborative Research Using Biosamples and/or Data from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
United States · Jan 15, 2025
Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC) (U24 Clinical Trial Not Allowed)
United States · May 7, 2026
Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal (U01 Research Project (Cooperative Agreement) Clinical Trial not allowed)
United States · Feb 6, 2026

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.